近10年成本-效用分析中EQ-5D与SF-6D应用现状的文献计量研究:基于PubMed数据库

The Bibliometric Analysis on the Application Status of EQ-5D and SF-6D in Cost-Utility Analysis in the Recent 10 Years:Based on PubMed Data Base

目的:分析欧洲5维健康量表(EQ-5D)与6维健康调查短表(SF-6D)在成本-效用分析研究中的应用现状。方法:以PubMed数据库为数据源对2003—2012年发表的相关文献进行文献计量分析。结果:近10年应用EQ-5D与SF-6D进行成本-效用分析的文献量未呈一定的增长趋势,主要的发表语言为英语,主要国家为英国。已形成6种核心期刊,核心作者尚未形成。文献所涉及的疾病分布广泛,且主要是运动系统和疼痛类疾病。效用绝大多数采用质量调整生命年表示,成本-效用分析的评价对象主要集中于药物、手术和健康干预3种。结论:应用EQ-5D与SF-6D进行成本-效用分析的文献及文献所研究内容分布范围均较广,虽然已经呈现出集中趋势,但未形成核心,有待于相关领域学者开展广泛的研究。

Objective： To analyze the application status of the EQ-5D and SF-6D in cost-utility analysis （CUA） . Methods： The data from PubMed data base from 2003-2012 was conducted as the main resource in econometric analysis. Results： There is no certain increasing trend of literature quantity in the recent 10 years＇ application of EQ-5D and SF-6D in the CUA. The main puhlished language was English and the main country was the United Kingdom. The core authors of researches on the CUA estimated by EQ-5D and SF-6D had nol been formed, however, the core periodicals had been formed. The literatures involve wide-spread diseases, mainly known as Motion system and pain diseases. Most of the effectiveness could be calculated with quality adjusted life year （QALY） , the object of CUA is mainly on the medicine, operation and heahh intervention. Conclusion： Appicating EQ-5D and SF-6D in CUA and research content of the literatures has wide distribution width, ahhough it has shown centralized trend, which still needs more studies by related researchers.